These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 8879373)

  • 1. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer.
    Glimelius B; Hoffman K; Sjödén PO; Jacobsson G; Sellström H; Enander LK; Linné T; Svensson C
    Ann Oncol; 1996 Aug; 7(6):593-600. PubMed ID: 8879373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.
    Glimelius B; Ekström K; Hoffman K; Graf W; Sjödén PO; Haglund U; Svensson C; Enander LK; Linné T; Sellström H; Heuman R
    Ann Oncol; 1997 Feb; 8(2):163-8. PubMed ID: 9093725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer.
    Glimelius B; Hoffman K; Graf W; Haglund U; Nyrén O; Påhlman L; Sjödén PO
    Ann Oncol; 1995 Mar; 6(3):267-74. PubMed ID: 7542021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas.
    Choi CW; Choi IK; Seo JH; Kim BS; Kim JS; Kim CD; Um SH; Kim JS; Kim YH
    Am J Clin Oncol; 2000 Aug; 23(4):425-8. PubMed ID: 10955877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer.
    Rao S; Cunningham D; Hawkins RE; Hill ME; Smith D; Daniel F; Ross PJ; Oates J; Norman AR
    Br J Cancer; 2005 May; 92(9):1650-4. PubMed ID: 15856037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic overview of chemotherapy effects in colorectal cancer.
    Ragnhammar P; Hafström L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience.
    Moretto R; Raimondo L; De Stefano A; Cella CA; Matano E; De Placido S; Carlomagno C
    Anticancer Drugs; 2013 Oct; 24(9):980-5. PubMed ID: 23928570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of clinical benefit of chemotherapy in patients with upper gastrointestinal cancer.
    Hoffman K; Glimelius B
    Acta Oncol; 1998; 37(7-8):651-9. PubMed ID: 10050982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospective randomized trial comparing 1/2 FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas (the 2nd trial in non-resectable patients). Japanese Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
    Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T; Yamauchi H; Ogata Y; Shimada H; Miyakawa S; Yamaguchi A; Sakoda K; Yasuda H; Tsukada K; Yoshida K; Ashida H; Ishikawa Y; Kotoura Y; Kinoshita H; Kajiwara T; Watanabe G; Uchimura M; Funabiki T; Ikeda S; Okada S
    Gan To Kagaku Ryoho; 1996 May; 23(6):707-14. PubMed ID: 8645022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas.
    Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T
    Oncology; 1994; 51(5):396-400. PubMed ID: 8052479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer.
    Huguier M; Barrier A; Valinas R; Flahault A; Adloff M; Pezet D; Jaeck D; Millat B;
    Hepatogastroenterology; 2001; 48(39):875-8. PubMed ID: 11462946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.
    Paccagnella A; Favaretto A; Oniga F; Barbieri F; Ceresoli G; Torri W; Villa E; Verusio C; Cetto GL; Santo A; De Pangher V; Artioli F; Cacciani GC; Parodi G; Soresi F; Ghi MG; Morabito A; Biason R; Giusto M; Mosconi P; Chiarion Sileni V;
    Lung Cancer; 2004 Jan; 43(1):83-91. PubMed ID: 14698542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer--a Groupe Tumeurs Digestives of the Federation Nationale des Centres de Lutte Contre le Cancer study.
    Conroy T; Paillot B; François E; Bugat R; Jacob JH; Stein U; Nasca S; Metges JP; Rixe O; Michel P; Magherini E; Hua A; Deplanque G
    J Clin Oncol; 2005 Feb; 23(6):1228-36. PubMed ID: 15718320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional chemotherapy in biliary tract cancers--a single institution experience.
    Melichar B; Cerman J; Dvorák J; Jandík P; Mergancová J; Melicharová K; Tousková M; Krajina A; Voboril Z
    Hepatogastroenterology; 2002; 49(46):900-6. PubMed ID: 12143237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current aspects of chemotherapy of metastatic pancreatic and biliary tract carcinomas].
    Bokemeyer C; Kollmannsberger C; Oettle H; Kanz L
    Praxis (Bern 1994); 2000 Sep; 89(39):1545-52. PubMed ID: 11068508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy Improves Survival After Percutaneous Biliary Drainage in Patients With Pancreatic or Biliary Tract Cancer With Biliary Obstruction.
    Niemelä J; Syrjälä H; Ohtonen P; Saarnio J; Kallio R
    Anticancer Res; 2021 Jun; 41(6):2979-2984. PubMed ID: 34083288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life Achieved by Carboplatin Plus Etoposide as Third-Line Chemotherapy Compared with Best Supportive Care in Non-Small Cell Lung Cancer Stage IIIB/IV.
    Maneechawakajorn J; Hathaisanguan S
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S175-81. PubMed ID: 27266233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of oxaliplatin combined with leucovorin and fluorouracil for recurrent/metastatic biliary tract carcinoma.
    Lim JY; Jeung HC; Mun HS; Lee DK; Paik YH; Lee SJ; Yoon DS; Cho JY
    Anticancer Drugs; 2008 Jul; 19(6):631-5. PubMed ID: 18525323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative MEFLEP therapy in advanced pancreatic cancer: excellent response in a patient with Her-2/neu amplification.
    Chao Y; Liu JM; Li AF; Perng CL; Tiu CM; King KL; Chen LT; Lin WC; Lan C; Whang-Peng J
    Pancreas; 2002 Jul; 25(1):e10-4. PubMed ID: 12131783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose etoposide in advanced pancreatic and biliary cancer, a phase II study.
    Ekstrom K; Hoffman K; Linne T; Eriksson B; Glimelius B
    Oncol Rep; 1998; 5(4):931-4. PubMed ID: 9625849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.